- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x MN: MANGANESE (II) ION(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
SO4.3: 6 residues within 4Å:- Chain A: I.50, E.51, T.52, N.53, K.54, S.195
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:E.51, A:E.51, A:T.52, A:N.53, A:N.53, A:K.54, A:S.195
SO4.4: 4 residues within 4Å:- Chain A: G.72, S.73, R.76, K.114
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.73
- Salt bridges: A:R.76, A:K.114
SO4.9: 6 residues within 4Å:- Chain B: I.50, E.51, T.52, N.53, K.54, S.195
7 PLIP interactions:7 interactions with chain B- Hydrogen bonds: B:E.51, B:E.51, B:T.52, B:N.53, B:N.53, B:K.54, B:S.195
SO4.10: 4 residues within 4Å:- Chain B: G.72, S.73, R.76, K.114
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.73
- Salt bridges: B:R.76, B:K.114
SO4.15: 6 residues within 4Å:- Chain C: I.50, E.51, T.52, N.53, K.54, S.195
7 PLIP interactions:7 interactions with chain C- Hydrogen bonds: C:E.51, C:E.51, C:T.52, C:N.53, C:N.53, C:K.54, C:S.195
SO4.16: 4 residues within 4Å:- Chain C: G.72, S.73, R.76, K.114
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:S.73
- Salt bridges: C:R.76, C:K.114
SO4.21: 6 residues within 4Å:- Chain D: I.50, E.51, T.52, N.53, K.54, S.195
7 PLIP interactions:7 interactions with chain D- Hydrogen bonds: D:E.51, D:E.51, D:T.52, D:N.53, D:N.53, D:K.54, D:S.195
SO4.22: 4 residues within 4Å:- Chain D: G.72, S.73, R.76, K.114
3 PLIP interactions:3 interactions with chain D- Hydrogen bonds: D:S.73
- Salt bridges: D:R.76, D:K.114
- 4 x KU0: 2-[(2S)-1-(3,5-dichloropyridine-4-carbonyl)pyrrolidin-2-yl]-5-hydroxy-6-oxo-N-[2-(phenylsulfonyl)ethyl]-1,6-dihydropyrimidine-4-carboxamide(Non-covalent)
KU0.5: 15 residues within 4Å:- Chain A: Y.44, K.54, I.58, H.61, E.81, F.106, L.107, D.109, D.120, I.121, Y.131, K.135, K.138
- Ligands: MN.1, MN.2
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:I.58
- Hydrogen bonds: A:K.54, A:Y.131, A:Y.131, A:K.135
- pi-Stacking: A:H.61
KU0.11: 15 residues within 4Å:- Chain B: Y.44, K.54, I.58, H.61, E.81, F.106, L.107, D.109, D.120, I.121, Y.131, K.135, K.138
- Ligands: MN.7, MN.8
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:I.58
- Hydrogen bonds: B:K.54, B:Y.131, B:Y.131, B:K.135
- pi-Stacking: B:H.61
KU0.17: 15 residues within 4Å:- Chain C: Y.44, K.54, I.58, H.61, E.81, F.106, L.107, D.109, D.120, I.121, Y.131, K.135, K.138
- Ligands: MN.13, MN.14
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:I.58
- Hydrogen bonds: C:K.54, C:E.81, C:D.109, C:Y.131, C:Y.131, C:K.135
- pi-Stacking: C:H.61
KU0.23: 15 residues within 4Å:- Chain D: Y.44, K.54, I.58, H.61, E.81, F.106, L.107, D.109, D.120, I.121, Y.131, K.135, K.138
- Ligands: MN.19, MN.20
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:I.58
- Hydrogen bonds: D:K.54, D:Y.131, D:Y.131, D:K.135
- pi-Stacking: D:H.61
- 4 x GOL: GLYCEROL(Non-functional Binders)
GOL.6: 6 residues within 4Å:- Chain A: R.171, T.174, R.175, T.178
- Chain D: E.78, V.91
5 PLIP interactions:5 interactions with chain A- Hydrogen bonds: A:R.171, A:R.171, A:R.175, A:T.178, A:T.178
GOL.12: 6 residues within 4Å:- Chain B: R.171, T.174, R.175, T.178
- Chain C: E.78, V.91
5 PLIP interactions:5 interactions with chain B- Hydrogen bonds: B:R.171, B:R.171, B:R.175, B:T.178, B:T.178
GOL.18: 6 residues within 4Å:- Chain A: E.78, V.91
- Chain C: R.171, T.174, R.175, T.178
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:R.171, C:R.171, C:R.175, C:T.178, C:T.178
GOL.24: 6 residues within 4Å:- Chain B: E.78, V.91
- Chain D: R.171, T.174, R.175, T.178
5 PLIP interactions:5 interactions with chain D- Hydrogen bonds: D:R.171, D:R.171, D:R.175, D:T.178, D:T.178
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beylkin, D. et al., Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease. Sci Rep (2017)
- Release Date
- 2017-12-27
- Peptides
- Polymerase acidic protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.35 Å
- Oligo State
- homo-tetramer
- Ligands
- 8 x MN: MANGANESE (II) ION(Non-covalent)
- 8 x SO4: SULFATE ION(Non-functional Binders)
- 4 x KU0: 2-[(2S)-1-(3,5-dichloropyridine-4-carbonyl)pyrrolidin-2-yl]-5-hydroxy-6-oxo-N-[2-(phenylsulfonyl)ethyl]-1,6-dihydropyrimidine-4-carboxamide(Non-covalent)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Beylkin, D. et al., Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease. Sci Rep (2017)
- Release Date
- 2017-12-27
- Peptides
- Polymerase acidic protein: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
AC
AD
A